- Home
- BLRX vs FCUV Comparison
BLRX vs FCUV Comparison
Compare BLRX & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- FCUV
- Stock Information
- Founded
- BLRX 2003
- FCUV 2012
- Country
- BLRX Israel
- FCUV United States
- Employees
- BLRX N/A
- FCUV N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- FCUV Industrial Machinery/Components
- Sector
- BLRX Health Care
- FCUV Industrials
- Exchange
- BLRX Nasdaq
- FCUV Nasdaq
- Market Cap
- BLRX 17.1M
- FCUV 15.9M
- IPO Year
- BLRX 2011
- FCUV N/A
- Fundamental
- Price
- BLRX $3.50
- FCUV $4.28
- Analyst Decision
- BLRX Strong Buy
- FCUV
- Analyst Count
- BLRX 2
- FCUV 0
- Target Price
- BLRX $19.00
- FCUV N/A
- AVG Volume (30 Days)
- BLRX 29.2K
- FCUV 56.2K
- Earning Date
- BLRX 11-24-2025
- FCUV 11-14-2025
- Dividend Yield
- BLRX N/A
- FCUV N/A
- EPS Growth
- BLRX N/A
- FCUV N/A
- EPS
- BLRX N/A
- FCUV N/A
- Revenue
- BLRX $17,251,000.00
- FCUV $432,983.00
- Revenue This Year
- BLRX N/A
- FCUV N/A
- Revenue Next Year
- BLRX N/A
- FCUV N/A
- P/E Ratio
- BLRX N/A
- FCUV N/A
- Revenue Growth
- BLRX 1.19
- FCUV 140.82
- 52 Week Low
- BLRX $2.30
- FCUV $1.80
- 52 Week High
- BLRX $22.60
- FCUV $10.90
- Technical
- Relative Strength Index (RSI)
- BLRX 37.77
- FCUV 57.30
- Support Level
- BLRX $3.51
- FCUV $3.87
- Resistance Level
- BLRX $3.89
- FCUV $5.25
- Average True Range (ATR)
- BLRX 0.24
- FCUV 0.49
- MACD
- BLRX -0.04
- FCUV -0.00
- Stochastic Oscillator
- BLRX 0.00
- FCUV 54.03
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.